|
|
||||||||
1 Human Performance Laboratory, University of Miami, Coral Gables, Florida 33124-2040; 2 College of Educational Studies, Western Michigan University, Kalamazoo, Michigan 49008; 3 Health Science Division, Indian River Community College, Fort Pierce 34981-5596; 4 HealthSouth Doctors' Hospital, Coral Gables, Florida 33146; 5 University of Miami, Diabetes Research Institute, Miami, Florida 33136; and 6 School of Physical and Health Education, Queen's University, Kinston, Ontario, Canada K7L 3N6
| |
ABSTRACT |
|---|
|
|
|---|
This study sought to determine whether visceral adipose tissue (VAT) and/or its anthropometric surrogates could significantly predict health-related variables (HRV) in overweight Caucasian (CC) (n = 36) and African-American (AA) (n = 30) women. With the use of magnetic resonance imaging, findings showed significantly higher volume and area of VAT (P < 0.0001 for both) as well as higher triacylglycerol (P = 0.009) in CC compared with AA women. Furthermore, VAT volume, race, and VAT volume × race interaction could significantly predict triacylglycerol (P = 0.0094), high-density lipoprotein cholesterol (P = 0.0057), insulin (P = 0.0002), and insulin resistance (P < 0.0001). Additionally, the VAT volume × race interaction for insulin (P = 0.040) and insulin resistance (P = 0.003) was significant. In a separate analysis, waist circumference and race predicted the identical variables. Our results support the use of volume or area of VAT in predicting HRV in CC women; however, its use in AA women appears limited. In contrast, waist circumference can provide a suitable VAT alternative for both CC and AA women; however, VAT clearly represents the more powerful predictor.
central obesity; serum lipoproteins; insulin; glucose; Caucasian women; African-American women
| |
INTRODUCTION |
|---|
|
|
|---|
CURRENT STATISTICS HAVE REVEALED that more than one out of every three adult women is overweight, with the largest percent, nearly 49%, being African-American (AA) women (27). These women also suffer more serious medical consequences, particularly with regard to insulin (Ins) resistance, hyperinsulinemia, diabetes, and coronary artery disease (CAD) mortality (3, 6, 22). However, not all overweight AA or Caucasian (CC) women fall victim to the metabolic perturbations associated with their excess weight, which may be more closely related to the central distribution of their weight. Excessive intra-abdominal fat or visceral adipose tissue (VAT) is significantly associated with glucose (Glu) intolerance, Ins resistance, and dyslipidemia (10), including elevated serum triacylglycerol (TG), and with reduced cardioprotective high-density lipoprotein (HDL) cholesterol. It is also associated with elevated systemic blood pressure (24).
With the advent of the more sophisticated computer technology, magnetic resonance imaging (MRI) techniques have been used to scan the intra-abdominal region and quantify the amount of the more hazardous VAT. Research supports measuring VAT area at one location to indicate the total amount of VAT; however, there is controversy regarding the optimal landmark to use when VAT area is measured in different racial populations (8, 36, 40). Although VAT volume and area at L4-L5 are similarly correlated with health-related variables (HRV) in obese men (37), we know of no studies examining this relationship in a mixed racial population of overweight women. Because there is no time penalty for acquiring multiple images and no X-ray radiation, it is just as easy to acquire several abdominal images as it is to acquire a single image. Thus it seems reasonable to examine whether VAT area at L4-L5 is an adequate surrogate measure for VAT volume in relation to HRV in overweight CC and AA women.
Conversely, anthropometric surrogates, such as waist circumference (WC), sagittal diameter (SD), and or waist-to-hip ratio (WHR), have provided a less expensive and more expedient alternative to the measurement of VAT. Again, there is controversy regarding the optimal anthropometric surrogates for VAT (7, 12, 20, 25), although WC and possibly SD have emerged as somewhat better surrogate measures (2, 20, 36). A more critical issue, however, is which anthropometric surrogate is the best predictor of HRV, which has been reported to be race dependent, differing between CC and AA women (7, 12, 23). Furthermore, research examining this question should also measure physical activity, stress, and nutrient intake in the same study to demonstrate that differences between groups are not related to these potential confounders.
We know of no studies evaluating the volume of VAT and its anthropometric surrogates to explain HRV among women and minorities while at the same time examining multiple confounders. Therefore, the purpose of this study was to determine whether the volume of VAT or its anthropometric surrogates could predict serum lipoproteins, blood pressure, and Ins resistance in a sample of overweight CC and AA women.
| |
METHODS |
|---|
|
|
|---|
Subjects. To participate in the study, subjects were required to be apparently healthy and premenopausal, displaying a body mass index (BMI) above 27.3 kg/m2 (50). Subjects who were pregnant or lactating; amenorrheic; or taking medications that would affect blood pressure, carbohydrate, or lipid metabolism were excluded from the study. Both parents and both grandparents had to be of the same racial descent for the subject to be considered CC or AA. A total of 66 subjects (36 CC; 30 AA) met all eligibility requirements and fulfilled the criteria necessary for completion of the study. Subjects completed all testing procedures in accordance with the guidelines set forth by the Human Subjects Institutional Review Board at the University of Miami.
Anthropometric measurements. Body weight was measured to the nearest 0.1 kg. Body height was measured to the nearest 0.5 cm, and BMI was calculated as weight (kg) divided by height (m2). Circumferences were measured with a Gulick II plastic spring-tension measuring tape (Gays Mill, WI). WC was measured midway between the lower rib margin and iliac crest, whereas hip circumference was measured at the outermost points of the greater trochanters (50). The WHR was the ratio calculated between these two circumferences. The SD of subjects was measured in a reclining position with an anthropometer placed in the same position as that used to determine WC. This procedure is reported to maintain the depth of the abdomen, thereby providing a more accurate assessment of VAT (44). All anthropometric measurements were performed by the same investigator, who recorded the mean of the two measurements to the nearest 1.0 mm.
Body composition analysis was performed by using bioelectrical impedance techniques (RJL System, Clinton Township, MI). This procedure is based on the premise that fat and lean tissue provide different levels of resistance to an electrical current passed through the body. Values recorded were entered into a gender- and obesity-specific equation reported by Segal et al. (41), which has been shown to provide an accurate assessment of body composition when validated against hydrodensitometry (17).Blood pressure. After an overnight fast, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken after subjects were in a seated position for a 5-min interval. Duplicate blood pressure measurements were taken from the left upper arm, averaged, and recorded to the nearest 2.0 mmHg with a 5-min interval separating measurements.
Serum measurements. Blood withdrawal from the antecubital vein occurred after a 12-h fast and was analyzed within a 1-wk period. Levels of total cholesterol (32) and HDL (48), HDL subfractions (16), and TG (29) were measured by a lipid laboratory within the Diabetes Research Institute, University of Miami. The very-low-density-lipoprotein (VLDL) cholesterol was estimated by TG divided by five, and low-density-lipoprotein (LDL) cholesterol was indirectly calculated by subtracting HDL and VLDL from total cholesterol (15). Serum standards used for calibration were developed by the Diabetes Research Institute and calibrated against serum samples from the Centers for Disease Control and Prevention Laboratory.
Apolipoprotein (apoB) in serum was measured by turbidimetric immunoassay by using a commercially available kit (Incstar, Stillwater, MN) according to the manufacturer's procedures. All apoB procedures have been developed in accordance with the guidelines set forth by the International Federation of Clinical Chemistry. All LDL subfractions were separated by gradient gel electrophoresis by using 2-16% nondenaturing polyacrylamide-agarose gels (Alamo Gels, San Antonio, TX) according to the procedures outlined by Kraus and Burke (26) and McNamara et al. (30). Fasting Glu levels were determined spectrophotometrically at a wavelength of 340 nm by using a hexokinase reaction developed by Roche (Roche Diagnostic System, Nutley, NJ). Serum Ins was measured by radioimmunoassay of serum by using a Coat-A-Count Ins procedure (Diagnostic Products, Los Angeles, CA). This procedure has been shown to have minimal cross-reactivity to compounds other than Ins and pro-Ins that might be present in serum samples. The Ins resistance (Ins/Glu) was assessed by using the homeostasis model assessment (HOMA) index, which divides the product of fasting Ins and Glu by 22.5 (19).MRI. The abdominal region was examined by using MRI with a 1.5-T instrument (Siemens Medical Systems, Iselin, NJ). Spin-echo imaging was performed by using a T1 weighted sequence with a 147-ms repetition time and 4.8 ms echo time. Slice thickness was 10 mm with a 2.5-mm interslice gap. A total of seven slices was obtained in each subject with the central slice of the acquisition centered at the L4-L5 disc level. Acquisition time was 26 s by using this imaging sequence, enabling imaging to be performed during a single breath hold.
Once obtained, MRI data were stored on magnetic tape and transferred to a stand-alone Silicon Graphics (Indy) workstation (Silicon Graphics, Mountain View, CA) by using software developed by Ross and colleagues (40) (Queen's University, Kingston, ON). The VAT was defined as adipose contained within the boundaries of the rectus abdominis, internal obliques, quadratus lumborum, and long back muscles. The subcutaneous adipose tissue (SAT) was defined as the adipose tissue located between the skin and this same group of muscles. The VAT volume was computed by summing the VAT area in each slice multiplied by the nominal slice thickness of 10 mm and converting to liters. The SAT volume was computed by using the identical technique.Diet record. Subjects were asked to keep a 3-day food log typical of their eating habits for 1 weekend day and 2 weekdays during the week preceding testing. Nutrient and alcohol intakes were analyzed by using a computerized analysis system (Dine Health Systems 1994). According to Basiotis et al. (4), a 3-day food log is sufficient to accurately assess nutrient intake. Subjects were also required to record the average number of cigarettes smoked daily.
Physical activity record. Subjects were administered the College Alumnus Questionnaire developed by Paffenbarger et al. (33) for assessing their participation in sports, recreational activities, and everyday physical activities. This questionnaire has been previously reported to be a reliable tool for the estimation of physical activity level in a similar group of subjects (1).
Education. This was measured by using a categorical scale that was modified from Rosmond et al. (39) On a 1-5 scale, all subjects had their education status evaluated accordingly: elementary school education received 1, vocational school education 2, senior high school education 3, undergraduate college education 4, and graduate school education 5.
Stress. All subjects completed the Daily Stress Inventory developed by Brantley et al. (5). This survey has been designed to evaluate minor psychological stress, and the survey has been shown to be a significant correlate of endocrine measures of stress.
Statistical methods.
Means ± SD of all variables were calculated for CC and AA women.
Differences between racial groups were assessed by using a Student's
t-test for unpaired samples. Tests for normality were done
on all physiological variables by using the Shapiro-Wilk W test.
Because TG was not normally distributed, a log10
transformation was performed, which adequately normalized the
distribution of this variable. To obtain a normalized distribution for
serum Glu levels, three outlying values (1 CC and 2 AA) were removed.
Students' t-tests were conducted with and without the three
outliers. Multiple-regression models were conducted to determine
whether VAT or its anthropometric surrogates and race and/or a VAT × race interaction could predict HRV. The same regression model was
repeated by substituting either percent body fat or SAT for VAT volume.
Additionally, several potential confounders (e.g., alcohol, stress)
were added to the VAT regression model to determine their contribution
to the variance in HRV. In all regression analyses, age was treated as
a nuisance variable and was regressed out of each HRV with the
residuals serving as the new criterion variables in the subsequent
multiple-regression analyses. To better understand significant
interactions, Pearson's product-moment correlation matrix was
performed by race after controlling for the effects of age. Partial
correlations between HRV and VAT volume and percent body fat were
performed after controlling for percent body fat and VAT volume,
respectively, in CC and AA women. A significance level of P
0.05 was selected.
| |
RESULTS |
|---|
|
|
|---|
Results of the Student's t-test on physical
characteristics (Table 1) indicated that
there were no significant differences between CC and AA women for any
of these measures.
|
Dietary information is presented in Table
2. It can be seen that there were no
significant differences between CC and AA women for any reported
nutrients. Substitution of absolute values in grams for the percentage
of total fat, saturated fat, and carbohydrates also resulted in no
significant differences between CC and AA women.
|
Table 3 presents the mean body
composition and fat distribution values for CC and AA women. As can be
seen, CC women had significantly higher VAT volume and area
(P < 0.0001 for both). There was also a trend toward a
higher age (P = 0.0631) and WC (P = 0.0584) in CC women.
|
Table 4 shows the similarity between CC
and AA women for HRV. The only significant difference between groups
was the higher TG level observed in CC women (P = 0.009). Serum Glu levels are presented after removal of three outliers;
however, there were no significant differences in serum Glu levels
either before or after their removal.
|
The multiple-regression analysis presented in Table
5 shows those HRV that could be
significantly predicted by VAT volume, race, and a VAT volume × race interaction. HRV that could not be significantly predicted are not
presented in this table. VAT volume was a significant and independent
contributor explaining the variance in TG, HDL cholesterol, Ins, and
Ins/Glu. It can be seen that VAT volume but not race contributed
significantly to the variance in log TGs, and because VAT volume was
greater in CC women, race differences in log TGs can be attributed
specifically to differences in VAT volume. To support this finding, we
reran a Student's t-test on log TGs in 13 CC and 13 AA
women matched for VAT area and found no significant differences in
their log TGs (4.90 ± 0.48 and 4.75 ± 0.54 for CC and AA
women, respectively; P = 0.44).
|
Of particular interest in Table 5 was the fact that the VAT volume × race interaction contributed significantly to the prediction of Ins
and Ins/Glu. Further evaluation showed that, after controlling for age,
CC women showed a strong and positive relationship between VAT volume
and Ins (r = 0.784; P < 0.0001) and Ins/Glu
(r = 0.793; P < 0.0001). Conversely, AA
women showed an essentially absent relationship [r =
0.061; P = not significant (NS) and r =
0.13; P = NS for Ins and Ins/Glu, respectively].
Addition of potential confounders to the regression model showed that
alcohol had a significant impact on HDL (r2 = 0.090; P = 0.016) and that self-reported stress
significantly impacted Ins and Ins/Glu (r2 = 0.068; P = 0.040 and r2 = 0.129; P = 0.005 for Ins and Ins/Glu, respectively).
To determine the contribution of VAT volume apart from general adiposity, we reran the multiple regression in Table 5, substituting percent body fat for VAT volume. We found that percent body fat failed to result in a model that could significantly predict either log TG or HDL. In contrast, total adiposity contributed significantly and independently to the variance in Ins (r2 = 0.1492; P = 0.0016) in a model that was significant (F = 4.2413; P = 0.007) and contributed significantly and independently to the variance in Ins/Glu (r2 = 0.1649; P = 0.0013) in a model that was also significant (F = 4.744; P = 0.0050). In contrast to VAT volume, there was no race effect for percent body fat in predicting either Ins (r2 = 0.0016; P = NS) or Ins-to-Glu ratio (r2 = 0.015; P = NS). Substitution of SAT for VAT volume yielded results similar to those for percent body fat. SAT volume significantly and independently contributed to the variance in Ins (r2 = 0.1264; P = 0.003) and Ins/Glu (r2 = 0.1417; P = 0.003), with both models being significant (F = 3.653; P = 0.017 and F = 4.120; P = 0.012 for Ins and Ins/Glu, respectively). Similar to percent body fat, there was neither a race effect nor race × SAT volume interaction for Ins or Ins/Glu.
Shown in Table 6 are the correlations of
HRV with VAT volume and percent body fat after controlling for percent
body fat and VAT volume, respectively. In CC women, correlations
between VAT volume and HRV were significant after controlling for
percent body fat, whereas partial correlations between percent body fat and HRV were nonsignificant in these women. In contrast, partial correlations between VAT volume and HRV were minimal and nonsignificant in AA women; however, there was a trend toward a significant
correlation and a stronger relationship between Ins/Glu and percent
body fat in these women (r = 0.3381; P = 0.091).
|
To determine whether the relationship between VAT and Ins or Ins/Glu
were due to differences in quantity of VAT, we performed the same
multiple-regression analysis on a subset of 13 CC and 13 AA women
matched for VAT area (within 2.0 cm2). When subjects were
paired, the mean VAT area was 101.20 and 101.40 cm2 for CC
and AA women, respectively (P = 0.99). As shown in
Table 7, Ins and Ins/Glu could be
significantly predicted by VAT area, race, and VAT area × race
interaction, with each predictor contributing significantly to the
variance in the model. On further evaluation, the correlation between
VAT area and Ins (r = 0.683) and Ins/Glu (r =
0.682) was positive and significant for CC women (P = 0.01 for both). Conversely, in AA women, the correlations between VAT area and Ins (r =
0.24) as well as Ins/Glu (r =
0.190) were negative and nonsignificant, thereby supporting the
divergent relationship in CC and AA women observed for the entire
sample. Furthermore, we found that 6 of the 13 matched CC and AA women had VAT areas below 110 cm, which is associated with minimal metabolic risk (49). The mean VAT area was 67.86 cm2 for
the six CC and AA women, respectively, with no significant differences
observed between the two races in either age or VAT area. The
correlation between VAT area and Ins and Ins/Glu was r2 = 0.856 (P = 0.029) and
r2 = 0.824 (P = 0.043),
respectively, for CC women, whereas in AA women it was
r2 =
0.362 (P = 0.479)
and r2 =
0.414 (P = 0.487), respectively.
|
Results obtained by using anthropometric surrogates for VAT volume and
area are shown in Table 8. Because there
were no significant interactions involving race and anthropometric
surrogates, the interaction was excluded from the regression analysis.
Results indicated the same HRV predicted by VAT and race could also be predicted by WC and race. Additionally, WC was a significant and independent predictor of the variance in HRV. The use of SD afforded the additional prediction of SBP but failed to predict the
cardioprotective HDL. Interestingly, race was a significant and
independent contributor to the variance in log TG by using either WC or
SD in the model. Conversely, WHR did not result in the significant
prediction of any HRV with the exception of log TG (F =
3.295; P = 0.043).
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, CC women showed significantly higher VAT volume and area than AA women having similar BMI values (P < 0.0001 for both). Given the lack of significant differences between CC and AA groups in potential confounders, higher VAT levels in CC women take on added clinical significance. The mean VAT area of 128.20 cm2 found in CC women exceeded the 110-cm2 critical threshold for increased CAD risk (49) and was more than 1.5 times higher than that observed for AA women. Conversely, significantly lower VAT levels in AA women may, in part, explain the blunted rise in CAD observed with increasing BMI levels in AA women (45).
Recently, there has been some speculation regarding the direct involvement of VAT in assessing one's CAD risk (14, 42). Although VAT drains into the portal vein, exposing the liver to increased concentrations of free fatty acids, investigators have questioned whether the amount of VAT is sufficient to impair the metabolic clearance of Ins leading to a state of hyperinsulinemia and perturbations in lipid metabolism (14). Our results indicated that TG, HDL cholesterol, Ins, and Ins/Glu could all be significantly predicted by VAT and race, with VAT contributing significantly to the variance in each model (Table 5). Therefore, our data corroborate the finding that VAT volume is predictive of HRV and that VAT area at L4-L5 is a viable alternative to VAT volume in both racial populations.
Total adiposity could also predict Ins and Ins/Glu similarly in CC and AA women; however, it was not as strong a predictor as VAT volume, which accounted for an extra 11.67% of the variance in Ins and an extra 15.28% of the variance in Ins/Glu. Because total adiposity could not predict log TG or HDL, VAT volume clearly represents the better predictor of HRV in a group of overweight women. Examination of our correlations, however, indicated that the ability of VAT to predict HRV was primarily mediated by the strength of that relationship observed in CC women.
One could speculate that the lesser relationship observed between VAT and Ins or Ins/Glu in AA women was due to the fact that they had lower VAT levels. However, in 6 of the 13 matched CC and AA women displaying low VAT areas, we found a significant relationship with Ins and Ins/Glu in CC women that was not observed in AA women. In fact, using the entire sample, we found 13 CC and 21 AA women displaying low VAT areas (<110 cm2) and showed the same trend indicated above. Thus it appears that a critical amount of VAT is not necessary to have a significant relationship with Ins or Ins/Glu.
It could be argued that, because Ins and Ins/Glu are strongly correlated (r = 0.975), the results of both variables are redundant. Ins, however, has been significantly and independently related to CAD and hypertension (9, 11, 38), and AA women show greater mortality from CAD (3, 6) and greater rates of hypertension than CC women (13). On the other hand, Ins/Glu, using the HOMA index, indicates risk for diabetes, and AA women have 100% greater risk for diabetes than CC men, whereas CC women have a 30% greater risk for diabetes than CC men (21). Thus the critical issue is that VAT volume was not able to predict either Ins or Ins/Glu (both of which represent different and relevant HRV) in AA women.
It should be pointed out that Albu and colleagues (2) did not find racial differences in the relationship between VAT area and Ins sensitivity. However, CC and AA subjects in that study had higher BMI and VAT levels than did subjects in the present study, with no racial differences observed for VAT area. They also used a dynamic model for examining Ins-Glu kinetics, which indicated peripheral Ins sensitivity. On the other hand, Dowling and Pi-Sunyer (12), using the identical measures of Ins sensitivity alluded to above, obtained results similar to ours. In their study, they used WHR cut points to indicate central and peripheral obesity and found significant differences between upper and lower body obesity and Ins sensitivity in CC women, whereas they found no differences between upper and lower body obesity and Ins sensitivity in AA women.
On the basis of the findings of our study, we can only speculate as to why we found no relationship between VAT and Ins and Ins/Glu in AA women. Research has shown a pituitary hyperresponsiveness occurring alone or in response to mental challenge that may play a role in the subsequent development of VAT and the related metabolic disorders of hyperinsulinemia and Ins resistance (31, 34, 35). Unfortunately, this has not been examined in a mixed racial population and should be examined further in both overweight CC and AA women. Interestingly, self-reported stress was the only confounder that significantly impacted both Ins (P = 0.040) and Ins/Glu (P = 0.005) in the present study. Thus we feel a more in-depth analysis of the hypothalamic-pituitary-adrenal axis function in response to stress may be relevant. There may also be a role for sex steroids in the development of VAT, hyperinsulinemia, and Ins resistance (18, 46). If there are significant differences between CC and AA women in sex steroids or in the impact of sex steroids on VAT or basal insulin levels, this, too, may account for differences in the relationship between VAT and Ins or Ins/Glu in CC and AA women. Certainly more research is needed to clarify this issue.
Finally, WC and SD were suitable anthropometric surrogates for predicting HRV. In fact, WC and race could predict the identical HRV as VAT and race (i.e., log TG, HDL, Ins, and Ins/Glu) and should be considered the best surrogate measure. Sjöström et al. (43) hypothesized that WC may be superior to VAT or other anthropometric surrogates because WC encompasses both SAT and VAT obtained in a single abdominal measurement and is closely associated with BMI. Our study showed that SAT area was >3.5 times the amount of VAT volume or area in both CC and AA women, and thus any WC measurement would reflect the dominance of SAT over VAT. Because the ability of SAT volume to significantly impact Ins and Ins/Glu occurs similarly for CC and AA women, WC is expected to be a better predictor of these variables in research using both CC and AA women. It should be recognized, however, that, in our study, VAT volume was clearly the stronger predictor of HRV, accounting for a larger percent of the variance (R2) in each model presented with less degrees of freedom (Table 5).
In conclusion, our study supports the use of VAT volume or area for predicting several HRV in CC women; however, its use in predicting either Ins or Ins/Glu appears significantly limited in AA women. Given their higher rates of diabetes and CAD mortality (3, 6, 22) as well as the fact that VAT levels were significantly lower in AA than CC women, the search for better predictors of HRV in AA women seems warranted. Anthropometric surrogates, specifically WC, can provide a suitable alternative to VAT for predicting several HRV in both CC and AA overweight women; however, it should be recognized that VAT was clearly the more powerful predictor of HRV in our study.
| |
ACKNOWLEDGEMENTS |
|---|
The authors acknowledge the help of Bill Leon, who performed all the magnetic resonance imaging scans at HealthSouth Doctors' Hospital.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: A. C. Perry, Univ. of Miami, PO Box 246085, Coral Gables, FL 33124 (E-mail: aperry{at}jaguar.ir.miami.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 8 October 1999; accepted in final form 27 March 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ainsworth, BE,
Leon AS,
Richardson MT,
Jacobs DR,
and
Paffenbarger RS, Jr.
Accuracy of the college alumnus physical activity questionnaire.
J Clin Epidemiol
46:
1403-1411,
1993[ISI][Medline].
2.
Albu, JB,
Murphy L,
Frager DH,
Johnson JA,
and
Pi-Sunyer FX.
Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.
Diabetes
46:
456-462,
1997[Abstract].
3.
American Heart Association.
Heart and Stroke Facts: 1995 Statistical Supplement. Dallas, TX: American Heart Association, 1994, p. 4-9.
4.
Basiotis, PP,
Welsh SO,
Cronin FJ,
Kelsay JL,
and
Mertz W.
Numbers of days of food intake records required to estimate individual and group nutrient intakes with defined confidence.
J Nutr
117:
1638-1641,
1987.
5.
Brantley, PJ,
Dietz LS,
McKnight GT,
Jones GN,
and
Tulley R.
Convergence between the daily stress and endocrine measures of stress.
J Consult Clin Psychol
56:
549-551,
1988[ISI][Medline].
6.
Centers for Disease Control.
Chronic Disease in Minority Populations. Atlanta, GA: US Dept. of Health and Human Services, Public Health Services, CDC, 1994.
7.
Conway, JM,
Hallfrisch J,
and
Wang P.
Sagittal diameter as predictor of visceral adipose tissue and risk for disease in overweight African-American women (Abstract).
Obes Res
4, Suppl1:
23S,
1996.
8.
Conway, JM,
Yanovski SZ,
Avila NA,
and
Hubbard VS.
Visceral adipose tissue difference in black and white women.
Am J Clin Nutr
61:
765-771,
1995
9.
DeFronzo, RA,
and
Ferrannini E.
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and artherosclerotic cardiovascular disease.
Diabetes Care
14:
173-194,
1991[Abstract].
10.
Després, JP.
Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome.
Exerc Sport Sci Rev
25:
271-300,
1997[Medline].
11.
Després, JP,
Lamarche B,
Maursiege P,
Cantin B,
Dagenais GR,
Moorjani S,
and
Lupién PJ.
Hyperinsulinemia as an independent risk factor for ischemic heart disease.
N Engl J Med
334:
952-957,
1996
12.
Dowling, HJ,
and
Pi-Sunyer FX.
Race-dependent health risks of upper body obesity.
Diabetes
42:
537-543,
1993[Abstract].
13.
Eisner, GM
Hypertension: racial differences.
Am J Kidney Dis
16:
35-40,
1990[ISI][Medline].
14.
Frayn, KN,
Samra JS,
and
Summers LK.
Visceral fat in relation to health: is it a major culprit or simply an innocent bystander (Letter)?
Int J Obes
21:
1191-1192,
1997.
15.
Friedwald, WT,
Levy RI,
and
Fredrickson DS.
Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge.
Clin Chem
18:
499-502,
1972[Abstract].
16.
Gidez, LI,
Miller GJ,
Burnstein M,
Slagle S,
and
Eder HA.
Separation and quantification of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.
J Lipid Res
23:
1206-1223,
1982[Abstract].
17.
Goran, MI,
and
Khaled MA.
Cross-validation of fat-free mass estimated from body density against bioelectrical resistance: effects of obesity and gender.
Obes Res
3:
531-539,
1995[Medline].
18.
Haffner, SM.
Sex hormone binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes.
Horm Res
45:
233-237,
1996[ISI][Medline].
19.
Haffner, SM,
Miettinen H,
and
Stern MP.
The homeostasis model in the San Antonio Heart Study.
Diabetes Care
20:
1087-1092,
1997[Abstract].
20.
Han, TS,
McNeill G,
Seidell JC,
and
Lean ME.
Predicting intra-abdominal fatness from anthropometric measures: the influence of stature.
Int J Obes
21:
587-593,
1997.
21.
Harris, MI.
Noninsulin-dependent diabetes mellitus in black and white Americans.
Diabetes Metab Rev
6:
71-90,
1990[ISI][Medline].
22.
Harris, MI.
Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the US population.
Diabetes Care
14:
639-648,
1991[Abstract].
23.
Hill, JO,
Sidney S,
Lewis CE,
Tolan K,
Scherzinger AL,
and
Stamm ER.
Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
Am J Clin Nutr
69:
381-387,
1999
24.
Kanai, H,
Mutsuzawa Y,
Kotani K,
Keno Y,
Kobatake T,
Nagai Y,
Fujioka S,
Tokunaga K,
and
Tarui S.
Close correlation of intra-abdominal fat accumulation to hypertension in obese women.
Hypertension
16:
484-490,
1990
25.
Kortelainen, ML,
and
Sörkioja T.
Coronary atherosclerosis and myocardial hypertrophy in relation to body fat distribution in healthy women: an autopsy study on 33 violent deaths.
Int J Obes
21:
43-49,
1997.
26.
Krauss, RM,
and
Burke DJ.
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
J Lipid Res
23:
97-104,
1982[Abstract].
27.
Kuczmarski, RJ,
Flegal KM,
Campbell SM,
and
Johnson CL.
Increasing prevalence of overweight among US adults: the National Health and Nutritional Examination Surveys, 1960 to 1991.
JAMA
272:
205-211,
1994[Abstract].
28.
Lovejoy, JC,
de la Bretonne JA,
Klemperer M,
and
Tulley R.
Abdominal fat distribution and metabolic risk factors: effects of race.
Metabolism
45:
1119-1124,
1996[ISI][Medline].
29.
McGowan, MW,
Artiss JD,
Strandbergh DR,
and
Zak B.
A peroxidase coupled method for the colorimetric determination of serum triglycerides.
Clin Chem
29:
538-542,
1983
30.
McNamara, JR,
Campos H,
Ordovas JM,
Peterson J,
Wilson PW,
and
Schaefer EJ.
Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study.
Arteriosclerosis
7:
483-490,
1987
31.
Moyer, AE,
Rodin J,
Grilo CM,
Cummings N,
Larson LM,
and
Rebuffé-Scrive M.
Stress-induced cortisol response and fat distribution in women.
Obes Res
2:
255-261,
1994[Medline].
32.
National Heart and Lung Institute.
Manual of Laboratory Operations Lipid Research Clinic Program: Lipid and Lipoprotein Analysis. Washington, DC: National Institutes of Health, 1974, vol. I. (DHEW Publ. no. 75-628)
33.
Paffenbarger, RS, Jr,
Blair SN,
Lee IM,
and
Hyde RT.
Measurement of physical activity to assess health effects in free-living populations.
Med Sci Sports Exerc
25:
60-70,
1993[ISI][Medline].
34.
Pasquali, R,
Cantobelli S,
Casimirri F,
Capelli M,
Bortoluzzi L,
Flamia R,
Labate AM,
and
Barbara L.
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.
J Clin Endocrinol Metab
77:
341-346,
1993[Abstract].
35.
Pasquali, R,
Gaglardi L,
Vicennati V,
Gambineri A,
Colitta D,
Ceroni L,
and
Casimirri F.
ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome.
Int J Obes Relat Metab Disord
23:
419-424,
1999[ISI][Medline].
36.
Pouliot, MC,
Després JP,
Lemieux S,
Moorjani S,
Bouchard C,
Tremblay A,
Nadeau A,
and
Lupien PJ.
Waist circumference and abdominal sagittal diameter: best anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.
Am J Cardiol
73:
460-468,
1994[ISI][Medline].
37.
Rissanen, J,
Hudson R,
and
Ross R.
Visceral adipose tissue, androgens, and plasma lipids in obese men.
Metabolism
43:
1318-1323,
1994[ISI][Medline].
38.
Ronnemaa, T,
Laakso M,
Pyorala K,
Kallio V,
and
Puukka P.
High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and non-diabetic subjects.
Arterioscler Thromb
11:
80-90,
1991
39.
Rosmond, R,
Lapidus L,
and
Björntorp P.
The influence of occupation and social factors on obesity and body fat distribution in middle-aged men.
Int J Obes
20:
599-607,
1996.
40.
Ross, R,
Leger L,
Morris D,
de Guise J,
and
Guardo R.
Quantification of adipose tissue by MRI: relationship with anthropometric variables.
J Appl Physiol
72:
787-795,
1992
41.
Segal, KR,
Van Loan M,
Fitzgerald PI,
Hodgdon JA,
and
Van Itallie TB.
Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study.
Am J Clin Nutr
47:
7-14,
1988
42.
Seidell, JC,
and
Bouchard C.
Visceral fat in relation to health: is it a major culprit or simply an innocent bystander?
Int J Obes
21:
626-631,
1997.
43.
Sjöström, CD,
Lissner L,
and
Sjöström L.
Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects.
Obes Res
5:
519-530,
1997[ISI][Medline].
44.
Sjöström, L.
A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total, and subcutaneous adipose tissue.
Int J Obes
12:
19-30,
1991.
45.
Stevens, J,
Keil JE,
Rust PF,
Tyroler HA,
Davis CE,
and
Gazes PC.
Body mass index and body girths as predictors of mortality in black and white women.
Arch Intern Med
152:
1257-1262,
1992[Abstract].
46.
Svendsen, OL,
Hassager C,
and
Christiansen C.
Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women.
Int J Obes Relat Metab Disord
17:
459-463,
1993[ISI][Medline].
47.
Van der Merwe, MT,
Wing JR,
Celgow LH,
Gray IP,
Lonn L,
Joffe BI,
and
Lonnroth PN.
Metabolic indices in relation to body composition changes during weight loss on Dexfenfluramine in obese women from two South African ethnic groups.
Int J Obes
20:
768-776,
1996.
48.
Warnick, GR,
and
Albers JJ.
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.
J Lipid Res
19:
65-76,
1978[Abstract].
49.
Williams, MJ,
Hunter GR,
Kekes-Szabo T,
Trueth MS,
Synder S,
Berland L,
and
Blaudeau T.
Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women.
Int J Obes
20:
613-617,
1996.
50.
World Health Organization.
Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. Geneva: World Health Organization, 1995. (Tech. Rep. Ser. 854)
This article has been cited by other articles:
![]() |
T. G. Babb, B. L. Wyrick, D. S. DeLorey, P. J. Chase, and M. Y. Feng Fat Distribution and End-Expiratory Lung Volume in Lean and Obese Men and Women Chest, October 1, 2008; 134(4): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Babb, K. G. Ranasinghe, L. A. Comeau, T. L. Semon, and B. Schwartz Dyspnea on Exertion in Obese Women: Association with an Increased Oxygen Cost of Breathing Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A Bray, K. A Jablonski, W. Y Fujimoto, E. Barrett-Connor, S. Haffner, R. L Hanson, J. O Hill, V. Hubbard, A. Kriska, E. Stamm, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1212 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saadeh Nonalcoholic Fatty Liver Disease and Obesity Nutr Clin Pract, February 1, 2007; 22(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B Albu, A. J Kovera, L. Allen, M. Wainwright, E. Berk, N. Raja-Khan, I. Janumala, B. Burkey, S. Heshka, and D. Gallagher Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gallagher, P. Kuznia, S. Heshka, J. Albu, S. B Heymsfield, B. Goodpaster, M. Visser, and T. B Harris Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue Am. J. Clinical Nutrition, April 1, 2005; 81(4): 903 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cossrow and B. Falkner Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2590 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Nicklas, K. E. Dennis, D. M. Berman, J. Sorkin, A. S. Ryan, and A. P. Goldberg Lifestyle Intervention of Hypocaloric Dieting and Walking Reduces Abdominal Obesity and Improves Coronary Heart Disease Risk Factors in Obese, Postmenopausal, African-American and Caucasian Women J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2003; 58(2): M181 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A Gower, R. L Weinsier, J. M Jordan, G. R Hunter, and R. Desmond Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and white women Am. J. Clinical Nutrition, November 1, 2002; 76(5): 923 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Weinsier, G. R Hunter, B. A Gower, Y. Schutz, B. E Darnell, and P. A Zuckerman Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss Am. J. Clinical Nutrition, November 1, 2001; 74(5): 631 - 636. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP |